Connection

Co-Authors

This is a "connection" page, showing publications co-authored by ROBERT DANTZER and ANNEMIEKE KAVELAARS.
Connection Strength

2.065
  1. Interleukin-10 resolves pain hypersensitivity induced by cisplatin by reversing sensory neuron hyperexcitability. Pain. 2020 10; 161(10):2344-2352.
    View in: PubMed
    Score: 0.190
  2. CD3+ T cells are critical for the resolution of comorbid inflammatory pain and depression-like behavior. Neurobiol Pain. 2020 Jan-Jul; 7:100043.
    View in: PubMed
    Score: 0.181
  3. Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice. Pain. 2019 06; 160(6):1459-1468.
    View in: PubMed
    Score: 0.173
  4. Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling. Neuropsychopharmacology. 2018 12; 43(13):2597-2605.
    View in: PubMed
    Score: 0.163
  5. Motivational changes that develop in a mouse model of inflammation-induced depression are independent of indoleamine 2,3 dioxygenase. Neuropsychopharmacology. 2019 01; 44(2):364-371.
    View in: PubMed
    Score: 0.161
  6. Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain. Brain Behav Immun. 2017 Nov; 66:94-102.
    View in: PubMed
    Score: 0.152
  7. Sickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expression. Behav Brain Res. 2016 Jan 15; 297:241-50.
    View in: PubMed
    Score: 0.135
  8. Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice. Brain Behav Immun. 2015 May; 46:147-53.
    View in: PubMed
    Score: 0.128
  9. Neuroinflammation and comorbidity of pain and depression. Pharmacol Rev. 2014; 66(1):80-101.
    View in: PubMed
    Score: 0.119
  10. The neuroimmune basis of fatigue. Trends Neurosci. 2014 Jan; 37(1):39-46.
    View in: PubMed
    Score: 0.118
  11. G protein-coupled receptor kinase 6 acts as a critical regulator of cytokine-induced hyperalgesia by promoting phosphatidylinositol 3-kinase and inhibiting p38 signaling. Mol Med. 2012 May 09; 18:556-64.
    View in: PubMed
    Score: 0.106
  12. GRK2 in sensory neurons regulates epinephrine-induced signalling and duration of mechanical hyperalgesia. Pain. 2011 Jul; 152(7):1649-1658.
    View in: PubMed
    Score: 0.099
  13. Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERK. J Neurosci. 2010 Sep 22; 30(38):12806-15.
    View in: PubMed
    Score: 0.095
  14. Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling. Pain. 2010 Sep; 150(3):550-560.
    View in: PubMed
    Score: 0.094
  15. Tonic Meningeal Interleukin-10 Upregulates Delta Opioid Receptor to Prevent Relapse to Pain. bioRxiv. 2023 Jun 09.
    View in: PubMed
    Score: 0.057
  16. Pifithrin-? Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function. Cancer Res. 2017 02 01; 77(3):742-752.
    View in: PubMed
    Score: 0.036
  17. Mechanisms of chemotherapy-induced behavioral toxicities. Front Neurosci. 2015; 9:131.
    View in: PubMed
    Score: 0.033
  18. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation. 2010 Aug 02; 7:43.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.